Bio-Works brings forward the publication of its interim report for the third quarter of 2026
Bio-Works has decided to bring forward the publication of its interim report for the third quarter of 2026 from Friday, 6 November to Friday, 30 October 2026.
The change is being made in light of the previously announced change of CEO, with Eva Lindskog assuming the role on 1 November 2026. By bringing forward the publication date, the report will be published before this change and thus under the CEO, Lone Carlbom, who has had operational responsibility for the company throughout the reporting period.
Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Arne Hauge, CFO, e-mail: arne.hauge@bio-works.com, phone: +46(0)8-502 705 83.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.